Chronic urotensin-II infusion induces diastolic dysfunction and enhances collagen production in rats
The vasoactive peptide urotensin-II (U-II) is likely to play a key causal role in cardiac remodeling that ultimately leads to heart failure. Its contribution, specifically to the development of diastolic dysfunction and the downstream intracellular signaling, however, remains unresolved. This study...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Journal |
Published: |
2017
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=74949086624&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/43360 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
id |
th-cmuir.6653943832-43360 |
---|---|
record_format |
dspace |
spelling |
th-cmuir.6653943832-433602017-09-28T06:55:18Z Chronic urotensin-II infusion induces diastolic dysfunction and enhances collagen production in rats Tran L. Kompa A. Kemp W. Phrommintikul A. Wang B. Krum H. The vasoactive peptide urotensin-II (U-II) is likely to play a key causal role in cardiac remodeling that ultimately leads to heart failure. Its contribution, specifically to the development of diastolic dysfunction and the downstream intracellular signaling, however, remains unresolved. This study interrogates the effect of chronic U-II infusion in normal rats on cardiac structure and function. The contribution of Rho kinase (ROCK) signaling to these pathophysiological changes is evaluated in cell culture studies. Chronic high-dose U-II infusion over 4 wk signifi-cantly impaired diastolic function in rats on echocardiography-derived Doppler indexes, including E-wave deceleration time (vehicle 56.7 ± 3.3 ms, U-II 118.0 ± 21.5 ms; P < 0.01) and mitral valve annulus peak early/late diastolic tissue velocity (vehicle 2.01 ± 0.19 ms, U-II 1.04 ± 0.25 ms; P < 0.01). A lower dose of U-II infusion (1 nmol·kg -1 · h -1 ) yielded comparable changes. Diastolic dysfunction was accompanied by molecular [significant increases in procollagen-α 1 (I) gene expression on real-time PCR] and morphological (increases in total collagen, P < 0.05, and collagen type-I protein deposition, P < 0.001) evidence of left ventricular (LV) fibrosis following high-dose U-II infusion. The ROCK inhibitor GSK-576371 (10 -7 to 10 -5 M) elicited concentration-dependent inhibition of U-II (10 -7 M)-stimulated cardiac fibroblast collagen synthesis and cardiac myocyte protein synthesis. Chronic U-II infusion causes diastolic dysfunction, caused by fibrosis of the LV. The in vitro data suggest that this may be in part occurring via a ROCK-dependent pathway. Copyright © 2010 the American Physiological Society. 2017-09-28T06:55:18Z 2017-09-28T06:55:18Z 2010-01-29 Journal 03636135 2-s2.0-74949086624 10.1152/ajpheart.00942.2009 https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=74949086624&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/43360 |
institution |
Chiang Mai University |
building |
Chiang Mai University Library |
country |
Thailand |
collection |
CMU Intellectual Repository |
description |
The vasoactive peptide urotensin-II (U-II) is likely to play a key causal role in cardiac remodeling that ultimately leads to heart failure. Its contribution, specifically to the development of diastolic dysfunction and the downstream intracellular signaling, however, remains unresolved. This study interrogates the effect of chronic U-II infusion in normal rats on cardiac structure and function. The contribution of Rho kinase (ROCK) signaling to these pathophysiological changes is evaluated in cell culture studies. Chronic high-dose U-II infusion over 4 wk signifi-cantly impaired diastolic function in rats on echocardiography-derived Doppler indexes, including E-wave deceleration time (vehicle 56.7 ± 3.3 ms, U-II 118.0 ± 21.5 ms; P < 0.01) and mitral valve annulus peak early/late diastolic tissue velocity (vehicle 2.01 ± 0.19 ms, U-II 1.04 ± 0.25 ms; P < 0.01). A lower dose of U-II infusion (1 nmol·kg -1 · h -1 ) yielded comparable changes. Diastolic dysfunction was accompanied by molecular [significant increases in procollagen-α 1 (I) gene expression on real-time PCR] and morphological (increases in total collagen, P < 0.05, and collagen type-I protein deposition, P < 0.001) evidence of left ventricular (LV) fibrosis following high-dose U-II infusion. The ROCK inhibitor GSK-576371 (10 -7 to 10 -5 M) elicited concentration-dependent inhibition of U-II (10 -7 M)-stimulated cardiac fibroblast collagen synthesis and cardiac myocyte protein synthesis. Chronic U-II infusion causes diastolic dysfunction, caused by fibrosis of the LV. The in vitro data suggest that this may be in part occurring via a ROCK-dependent pathway. Copyright © 2010 the American Physiological Society. |
format |
Journal |
author |
Tran L. Kompa A. Kemp W. Phrommintikul A. Wang B. Krum H. |
spellingShingle |
Tran L. Kompa A. Kemp W. Phrommintikul A. Wang B. Krum H. Chronic urotensin-II infusion induces diastolic dysfunction and enhances collagen production in rats |
author_facet |
Tran L. Kompa A. Kemp W. Phrommintikul A. Wang B. Krum H. |
author_sort |
Tran L. |
title |
Chronic urotensin-II infusion induces diastolic dysfunction and enhances collagen production in rats |
title_short |
Chronic urotensin-II infusion induces diastolic dysfunction and enhances collagen production in rats |
title_full |
Chronic urotensin-II infusion induces diastolic dysfunction and enhances collagen production in rats |
title_fullStr |
Chronic urotensin-II infusion induces diastolic dysfunction and enhances collagen production in rats |
title_full_unstemmed |
Chronic urotensin-II infusion induces diastolic dysfunction and enhances collagen production in rats |
title_sort |
chronic urotensin-ii infusion induces diastolic dysfunction and enhances collagen production in rats |
publishDate |
2017 |
url |
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=74949086624&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/43360 |
_version_ |
1681422363272413184 |